Crystal International Gr Stock (OTC: CRYIF)

Latest news for Crystal International Gr (OTC:CRYIF) Stock

Crystal International Group Ltd is principally engaged in the manufacturing and trading of garments. Its operating segments include Lifestyle wear, Denim, Intimate, Sweater, Sportswear, and Outdoor Apparel. It generates a majority of its revenue from Lifestyle wear. Geographically, it generates the majority of revenue from the Asia Pacific which includes Japan, China, Hong Kong, and South Korea.

CRYSTAL INTL GROUP LTD by Crystal International Group Ltd.

Crystal International Group Ltd

Guggenheim analyst John Difucci maintains Dynatrace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DT#NYSE">DT</a>) with a Buy and lowers the price target from $60 to $55.

News

Price Target

Analyst Ratings

Guggenheim Maintains Buy on Dynatrace, Lowers Price Target to $55

Financial giants have made a conspicuous bullish move on CVS Health. Our analysis of options history for CVS Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) revealed 10 unusual trades.
Delving into the details, we found 50% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $303,820, and 7 were calls, valued at $615,689.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $50.0 to $70.0 for CVS Health during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in CVS Health's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to CVS Health's substantial trades, within a strike price spectrum from $50.0 to $70.0 over the preceding 30 days.
<h3>CVS Health Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721148399_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CVS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.7</td>
<td>$2.91</td>
<td>$4.7</td>
<td>$70.00</td>
<td>$304.6K</td>
<td>20.5K</td>
<td style="text-align: right;">44</td>
</tr>
<tr>
<td>CVS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$5.15</td>
<td>$5.05</td>
<td>$5.15</td>
<td>$60.00</td>
<td>$153.4K</td>
<td>4.8K</td>
<td style="text-align: right;">17</td>
</tr>
<tr>
<td>CVS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$5.4</td>
<td>$4.2</td>
<td>$4.65</td>
<td>$70.00</td>
<td>$122.3K</td>
<td>20.5K</td>
<td style="text-align: right;">692</td>
</tr>
<tr>
<td>CVS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$3.55</td>
<td>$3.5</td>
<td>$3.55</td>
<td>$57.50</td>
<td>$88.7K</td>
<td>839</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>CVS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$5.75</td>
<td>$5.7</td>
<td>$5.75</td>
<td>$57.50</td>
<td>$73.6K</td>
<td>990</td>
<td style="text-align: right;">8</td>
</tr>
</tbody>
</table>

<h3>About CVS Health</h3>
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the us. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.
Following our analysis of the options activities associated with CVS Health, we pivot to a closer look at the company's own performance.
<h3>CVS Health's Current Market Status</h3>
<ul>
<li>With a volume of 3,907,432, the price of CVS is up 1.67% at $59.65. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 22 days.</li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for CVS Health with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Markets

Market Whales and Their Recent Bets on CVS Options

Deep-pocketed investors have adopted a bullish approach towards D.R. Horton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DHI usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 22 extraordinary options activities for D.R. Horton. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 63% leaning bullish and 31% bearish. Among these notable options, 4 are puts, totaling $117,072, and 18 are calls, amounting to $606,586.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $100.0 to $180.0 for D.R. Horton during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for D.R. Horton's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of D.R. Horton's whale trades within a strike price range from $100.0 to $180.0 in the last 30 days. 
<h3>D.R. Horton Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721148394_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$11.8</td>
<td>$11.7</td>
<td>$11.8</td>
<td>$160.00</td>
<td>$58.3K</td>
<td style="text-align: right;">606</td>
<td style="text-align: right;">684</td>
</tr>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$2.05</td>
<td>$1.55</td>
<td>$1.55</td>
<td>$175.00</td>
<td>$52.1K</td>
<td style="text-align: right;">214</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$11.5</td>
<td>$10.8</td>
<td>$11.48</td>
<td>$160.00</td>
<td>$41.8K</td>
<td style="text-align: right;">606</td>
<td style="text-align: right;">10</td>
</tr>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$11.6</td>
<td>$11.2</td>
<td>$11.6</td>
<td>$160.00</td>
<td>$41.6K</td>
<td style="text-align: right;">606</td>
<td style="text-align: right;">381</td>
</tr>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$11.6</td>
<td>$11.2</td>
<td>$11.6</td>
<td>$160.00</td>
<td>$39.3K</td>
<td style="text-align: right;">606</td>
<td style="text-align: right;">381</td>
</tr>
</tbody>
</table>

<h3>About D.R. Horton</h3>
D.R. Horton is a leading homebuilder in the United States with operations in 118 markets across 33 states. D.R. Horton mainly builds single-family detached homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. D.R. Horton's headquarters are in Arlington, Texas, and it manages six regional segments across the United States.
In light of the recent options history for D.R. Horton, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of D.R. Horton</h3>
<ul>
<li>With a trading volume of 1,522,498, the price of DHI is up by 5.16%, reaching $160.0.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 2 days from now.</li>
</ul>
<h3>What Analysts Are Saying About D.R. Horton</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $176.33333333333334.
<ul>
<li>Reflecting concerns, an analyst from Citigroup lowers its rating to Neutral with a new price target of $156.</li>
<li>An analyst from Evercore ISI Group persists with their Outperform rating on D.R. Horton, maintaining a target price of $205. </li>
<li>An analyst from Barclays has decided to maintain their Overweight rating on D.R. Horton, which currently sits at a price target of $168. </li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for D.R. Horton, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

This Is What Whales Are Betting On D.R. Horton

TYSON 2.0, the champ&#8217;s cannabis brand announced a collaboration with vape manufacturer Holiday to bring a premium cannabis vape collection to New York consumers.
The new partnership, announced Tuesday, introduces a limited release of disposable vapes in three flavors featuring the following strains:
<ul>
<li>Knockout OG &#8211; OG indica, known for its powerful sedative effects features a flavor that's a blend of spicy fuel and earthy pine;</li>
<li>Haymaker Haze &#8211; a potent sativa, it's a haze cross from TYSON 2.0 that delivers calming, cerebral, and euphoric energy. The strain offers a sweet, spicy, and earthy smoke; and</li>
<li>Gelato 44 &#8211; Also known as Gelato #33 or Larry Bird, a slightly Indica-dominant hybrid, featuring a delightful mix of sweet orange and blueberry flavors.</li>
</ul>
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/06/39549015/washingtonians-share-my-high-expectations-for-high-quality-cannabis-says-mike-tyson-as-his-produ">&#8216;Washingtonians Share My High Expectations&#8217; For High-Quality Cannabis Says Mike Tyson As His Products Reach The Evergreen State</a>
&#8220;Working with Holiday to create these new vape products has been an incredible experience,&#8221; said Mike Tyson, chief brand officer and co-founder of TYSON 2.0, who personally tests and selects each strain to ensure products meet the highest standards. &#8220;Each flavor reflects our dedication to quality and the unique characteristics of my favorite cannabis strains. We&#8217;re excited to offer something truly special to our customers, and I believe these vapes will be a knockout.&#8221;
Adam Wilks, CEO of Carma HoldCo, the parent company of TYSON 2.0. shared Tyson's enthusiasm.
&#8220;By combining the strengths of TYSON 2.0 and Holiday, we&#8217;re able to deliver a product that not only meets but exceeds consumer expectations," Wilks said. "This new line of disposable vapes is a testament to our commitment to innovation and quality.&#8221;
<h3 class="wp-block-heading">Here's Where To Find Them</h3>
The new disposable vapes are available for limited release at select New York dispensaries including Strain Stars, MJ Dispensary, FlynnStoned Cannabis Company, Leafy Peaks, Housing Works Cannabis Co and Culture House Dispensary.
Tyson and Carma HoldCo first debuted their Tyson 2.0 cannabis brand&nbsp;in <a href="https://www.benzinga.com/markets/cannabis/23/11/35973754/mike-tysons-weed-products-are-hitting-the-shelves-in-new-york-heres-where-to-find-them">New York via a partnership with Hudson Cannabis in 2023.</a>
"As a native New Yorker myself, I'm thrilled to bring Tyson 2.0 to my hometown,&#8221; Tyson, who has spoken at <a href="https://www.benzinga.com/markets/cannabis/23/04/31759637/exclusive-tyson-2-0-announces-5-country-partnership-at-benzinga-cannabis-capital-conference">previous Benzinga cannabis events</a>, said at the time. &#8220;This brand represents a culmination of my personal journey towards holistic well-being and my belief in the power of cannabis to promote a balanced lifestyle.&#8221; 
The 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. <a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">Get your tickets now</a> before prices surge by following <a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">this link</a>.
Read Next:
Exclusive: <a href="https://www.benzinga.com/markets/cannabis/24/04/38241174/exclusive-mike-tysons-cannabis-brand-tyson-2-0-partners-with-phcann-international-in-germany-uk-">Mike Tyson&#8217;s Cannabis Brand TYSON 2.0 Partners With PHCANN International In Germany &amp; UK, Expanding European Footprint</a>

Cannabis

Entrepreneurship

Mike Tyson's Cannabis Brand Partners With Holiday Vape Maker: Get Ready New Yorkers For New Products

Financial giants have made a conspicuous bullish move on Robinhood Markets. Our analysis of options history for Robinhood Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) revealed 12 unusual trades.
Delving into the details, we found 50% of traders were bullish, while 41% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $70,550, and 10 were calls, valued at $465,794.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $13.0 to $35.0 for Robinhood Markets during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Robinhood Markets's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Robinhood Markets's whale trades within a strike price range from $13.0 to $35.0 in the last 30 days. 
<h3>Robinhood Markets Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721148389_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/02/24</td>
<td>$3.8</td>
<td>$3.7</td>
<td>$3.72</td>
<td>$21.00</td>
<td>$111.5K</td>
<td>1.4K</td>
<td style="text-align: right;">905</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$1.3</td>
<td>$1.24</td>
<td>$1.3</td>
<td>$26.00</td>
<td>$65.0K</td>
<td>13.1K</td>
<td style="text-align: right;">4</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$3.05</td>
<td>$3.0</td>
<td>$3.01</td>
<td>$23.00</td>
<td>$60.2K</td>
<td>13.1K</td>
<td style="text-align: right;">667</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$4.0</td>
<td>$3.85</td>
<td>$3.94</td>
<td>$25.00</td>
<td>$55.1K</td>
<td>53.9K</td>
<td style="text-align: right;">86</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$12.2</td>
<td>$12.0</td>
<td>$12.0</td>
<td>$15.00</td>
<td>$36.0K</td>
<td>5.9K</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>

<h3>About Robinhood Markets</h3>
Robinhood Markets Inc is creating a modern financial services platform. It designs its own products and services and delivers them through a single, app-based cloud platform supported by proprietary technology. Its vertically integrated platform has enabled the introduction of new products and services such as cryptocurrency trading, dividend reinvestment, fractional shares, recurring investments, and IPO Access. It earns transaction-based revenues from routing user orders for options, equities, and cryptocurrencies to market makers when a routed order is executed.
Following our analysis of the options activities associated with Robinhood Markets, we pivot to a closer look at the company's own performance.
<h3>Where Is Robinhood Markets Standing Right Now?</h3>
<ul>
<li>With a volume of 9,542,766, the price of HOOD is up 2.11% at $24.45. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 22 days.</li>
</ul>
<h3>Professional Analyst Ratings for Robinhood Markets</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $22.0.
<ul>
<li>Showing optimism, an analyst from Wolfe Research upgrades its rating to Outperform with a revised price target of $29. </li>
<li>Consistent in their evaluation, an analyst from Deutsche Bank keeps a Hold rating on Robinhood Markets with a target price of $20. </li>
<li>Consistent in their evaluation, an analyst from Goldman Sachs keeps a Neutral rating on Robinhood Markets with a target price of $21. </li>
<li>Maintaining their stance, an analyst from Barclays continues to hold a Underweight rating for Robinhood Markets, targeting a price of $20. </li>
<li>An analyst from Piper Sandler has decided to maintain their Neutral rating on Robinhood Markets, which currently sits at a price target of $20. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Robinhood Markets options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

HOOD

Behind the Scenes of Robinhood Markets's Latest Options Trends

Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) is reporting its second-quarter earnings on Wednesday. Wall Street expects $2.7 in EPS and $22.3 billion in revenues as the company reports<a href="https://www.benzinga.com/calendars/earnings?tickers=JNJ"> before market hours</a>.
The stock is down 5.56% over the past year, -4.16% YTD.
Let&#8217;s look at what the charts indicate for Johnson &amp; Johnson stock and how the stock currently maps against Wall Street estimates.
<h1 class="wp-block-heading">Johnson &amp; Johnson Technical Setup Ahead Of Q2 Earnings </h1>
Johnson &amp; Johnson stock is exhibiting a strongly bullish trend, as its share price is above the 5-, 20-, and 50-day exponential moving averages.
<figure class="wp-block-image size-full"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071624&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="630" height="450" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/16112808/Screenshot-2024-07-16-at-8.57.41-PM.png" alt="" class="wp-image-438872" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/16112808/Screenshot-2024-07-16-at-8.57.41-PM.png 630w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/16112808/Screenshot-2024-07-16-at-8.57.41-PM-300x214.png 300w" sizes="(max-width: 630px) 100vw, 630px" /></a></figure>
<a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071624&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
Currently priced at $150.17, the stock is trading above its 8-day simple moving average (SMA) of $148.43, its 20-day SMA of $147.44, and its 50-day SMA of $148.12, all of which are bullish indicators.
<figure class="wp-block-image size-full"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071624&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="630" height="450" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/16112827/Screenshot-2024-07-16-at-8.57.11-PM.png" alt="" class="wp-image-438873" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/16112827/Screenshot-2024-07-16-at-8.57.11-PM.png 630w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/16112827/Screenshot-2024-07-16-at-8.57.11-PM-300x214.png 300w" sizes="(max-width: 630px) 100vw, 630px" /></a></figure>
<a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071624&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
The Moving Average Convergence Divergence (MACD) indicator also suggests a bullish outlook with a reading of 0.50. However, some caution is warranted due to slight selling pressure and its price being below the 200-day SMA of $153.37, which is a bearish signal. 
Additionally, the Relative Strength Index (RSI) at 60.62 indicates the stock is heading towards the Overbought territory, while Bollinger Bands (25) suggest a bullish signal, with the stock trading near the upper bound of $150.31.
Read Also: <a href="https://www.benzinga.com/news/earnings/24/07/39790748/how-to-earn-500-a-month-from-johnson-johnson-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Johnson &amp; Johnson Stock Ahead Of Q2 Earnings</a>
<h2 class="wp-block-heading">Johnson &amp; Johnson Analysts Consensus Ratings</h2>
Ratings &amp; Consensus Estimates:<a href="https://www.benzinga.com/quote/JNJ/analyst-ratings"> The consensus analyst rating</a> on Johnson &amp; Johnson stock stands at a Neutral currently with a price target of $171.24. However, the three most recent analyst ratings for the stock were released by Cantor Fitzgerald on July 1, June 25, and June 20, 2024. These ratings have an average price target of $215, suggesting an implied upside of 43.21% for the stock.
JNJ Price Action: Johnson &amp; Johnson stock was trading up 0.84% at $150.50 at the time of publication Tuesday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39696693/johnson-johnson-faces-medtech-challenges-but-is-on-track-to-meet-2024-guidance-gold">Johnson &amp; Johnson Faces MedTech Challenges But Is &#8216;On Track&#8217; To Meet 2024 Guidance: Goldman Sachs</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Health Care

Technicals

Trading Ideas

General

Johnson & Johnson: Bullish Charts Signal Strong Setup Before Q2 Earnings

XPeng Inc &#8211; ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) shares are trading higher by 4.8% to $8.77 during Tuesday&#8217;s session. The stock is rebounding following China's announcement of a <a href="https://www.benzinga.com/news/24/07/39768528/alibaba-chinese-tech-stocks-and-ev-stocks-nio-xpeng-li-auto-tumble-after-disappointing-economic-repo">lower-than-expected GDP growth</a> of 4.7% for the second quarter. Analysts had predicted a growth rate of 5.1%.
The economic report indicates a slowdown in retail sales growth and rising unemployment, which can lead to reduced consumer confidence. When consumers are less confident about their economic prospects, they are less likely to make big purchases, such as cars. This directly impacts sales for companies like XPeng.
The economic report also mentions deflationary pressures leading to price cuts on various goods, including cars. If deflation is forcing car prices down, this can squeeze profit margins for XPeng and other auto manufacturers, making their stocks less attractive to investors.
Read Also: <a href="https://www.benzinga.com/news/24/07/39765072/mohamed-el-erian-notes-chinas-q2-gdp-growth-disappoints-at-4-7-amid-real-estate-woes">Mohamed El-Erian Notes China's Q2 GDP Growth Disappoints At 4.7% Amid Real Estate Woes</a>
<h2 class="wp-block-heading">How To Buy XPEV Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in XPeng&#8217;s case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, XPEV has a 52-week high of $23.62 and a 52-week low of $6.55.

XPEV

What's Going On With XPeng (XPEV) Stock?

Advanced Micro Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) has unveiled its latest AI PC architecture, incorporating a new neural processing unit (NPU) in its AMD Ryzen AI chips.
This announcement was made at the Computex trade show in Taiwan last month, followed by a detailed presentation at a recent event in Los Angeles, VentureBeat <a target="_blank" href="https://venturebeat.com/ai/amd-takes-a-deep-dive-into-architecture-for-the-ai-pc-chips/" rel="noreferrer noopener">reports</a>.
The new NPU technology can handle AI workloads with remarkable efficiency.
Also Read: <a target="_blank" href="https://www.benzinga.com/m-a/24/07/39725192/amd-challenges-nvidia-with-strategic-665m-purchase-of-finnish-ai-lab" rel="noreferrer noopener">AMD Challenges Nvidia With Strategic $665M Purchase Of Finnish AI Lab</a>
According to Vamsi Boppana, AMD's SVP of AI, the NPUs can operate AI models at 35 times the performance per watt of a standard CPU and eight times that of an integrated GPU.
AMD's AI PCs provide enhanced privacy by containing data within local networks, reducing the need for cloud-based processing.
The latest AMD Ryzen AI chips integrate 16 RDNA 3.5 GPU compute units and 12 Zen CPU cores, and thanks to the XDNA 2 architecture, they offer 50 TOPS.
AMD's XDNA 2 architecture features 32 AI engines and 50 NPU TOPS, which supports various applications, including immersive collaboration, creative editing, gaming, personal AI assistance, and enterprise productivity.
AMD stock gained 52% in the last 12 months, buoyed by <a target="_blank" href="https://www.benzinga.com/news/24/07/39772563/whats-going-on-with-ai-stocks-nvidia-amd-on-monday" rel="noreferrer noopener">the AI wave</a>. Investors can gain exposure to the stock through Vanguard Growth ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VUG#NYSE">VUG</a>) and VanEck Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMH#NASDAQ">SMH</a>).
Price Action: AMD is down 2.04% at $176.17 at the last check on Tuesday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
<h2 class="wp-block-heading">Is AMD A Good Stock To Buy?</h2>
Wall Street analysts view Advanced Micro Devices on the whole as a Outperform, given the history of coverage over the past three months. Christopher Danely from Citigroup in Advanced Micro Devices is the most optimistic, expecting a 19.32% rise in the stock in the coming year.
But looking at how the market as a whole thinks of the stock, you can reference historical price action for views on whether investors feel strongly about the stock one way or another. In the past 3 months, Advanced Micro Devices rose 12.83%, which indicates that opinion improved on the business and how attractive it is to own based on either its stock price, or underlying fundamentals, like revenue, which rose 2.24% over the past year.
A complete overview of how Wall Street views individual stocks is available <a href="https://www.benzinga.com/analyst-stock-ratings">here</a>, while real time updates on the latest analyst actions will be delivered via <a href="https://pro.benzinga.com">Benzinga PRO</a>. Try it for free.
Photo courtesy of AMD.

Tech

Media

AMD Showcases New AI Capabilities with Ryzen AI Chips: Report

One of the original "meme stocks" Koss Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOSS#NASDAQ">KOSS</a>) shares are climbing Tuesday on heavy trading volume. Here's a<a href="https://www.benzinga.com/news/24/07/39647722/whats-going-on-with-koss-stock"> look at what's going on.&nbsp;</a>
What To Know:
Koss shares exploded higher in early July as retail investors circulated a<a href="https://www.reddit.com/r/Superstonk/comments/1dtv3zj/the_gme_koss_connection_the_spark_to_ignite_the/"> social media post</a> speculating on a possible connection between GameStop Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) and Koss. The post attempted to extract a pattern from a series of emojis posted by Roaring Kitty, and some investors speculated that Koss could be the next stock Roaring Kitty will target based on the sequence of emojis.&nbsp;
Koss gave back a large portion of its gains from the beginning of July, however the stock remains up by more than 150% over the past month. Koss is moving higher on heavy volume Tuesday with more than triple the stock's average daily volume already traded in the session, according to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>
Read Next: <a href="https://www.benzinga.com/news/24/07/39776035/solar-stocks-tumble-following-failed-assassination-of-trump-whats-going-on">Solar Stocks Tumble Following Failed Assassination Of Trump: What&#8217;s Going On?</a>
Koss <a href="https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/12035096">was granted</a> a U.S. patent for "personal acoustic systems and flexible earpiece mounts for the same" last week, though the stock is moving Tuesday despite a lack of company-specific news.&nbsp;
According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Koss shares are trading above the stock&#8217;s 50-day moving average of $5.25 and 11.91% of available shares are being sold short.&nbsp;
<h2 class="wp-block-heading">How To Buy KOSS Stock:</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Koss&#8217; case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
KOSS Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Koss Corporation shares are up 18.7% at $10.35 at the time of publication Tuesday.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39777940/whats-going-on-with-upstart-stock">What&#8217;s Going On With Upstart Stock?</a></li>
</ul>
Image: Shutterstock

Movers

KOSS

What's Going On With Koss Stock?

Cantor Fitzgerald analyst C J Muse maintains Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) with a Neutral and raises the price target from $120 to $180.

Cantor Fitzgerald Maintains Neutral on Teradyne, Raises Price Target to $180

Morgan Stanley analyst John Glass maintains Brinker International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAT#NYSE">EAT</a>) with a Underweight and raises the price target from $42 to $50.

Morgan Stanley Maintains Underweight on Brinker International, Raises Price Target to $50

Cantor Fitzgerald analyst C J Muse maintains Seagate Tech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) with a Neutral and raises the price target from $100 to $120.

Cantor Fitzgerald Maintains Neutral on Seagate Tech Hldgs, Raises Price Target to $120

Macro Economic Events

Politics

Legal

Economics

Biden Campaign To Resume Advertising Suspended Following Trump Assassination Attempt

Cantor Fitzgerald analyst C J Muse maintains Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) with a Neutral and raises the price target from $190 to $215.

QCOM

Cantor Fitzgerald Maintains Neutral on Qualcomm, Raises Price Target to $215

Former President Donald Trump has selected Senator J.D. Vance (R-Ohio) to be his running mate in the<a href="https://www.benzinga.com/general/politics/24/07/39780777/trump-picks-senator-j-d-vance-as-running-mate-musk-says-great-choice-for-vp"> 2024 presidential election.</a>
The Senator has grown in popularity in the Republican Party in recent years, but many across the nation may be unfamiliar with his history. Here's a look at five things you might not know about the vice-presidential candidate.
"Hillbilly Elegy" Author: Vance is the author of the 2016 memoir "Hillbilly Elegy," which was also turned into a movie that Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) had the distribution rights to and <a href="https://www.benzinga.com/topic/streaming-stocks">now streams on their platform.</a>
The book, which is <a href="https://www.amazon.com/Hillbilly-Elegy-Memoir-Family-Culture/dp/0062300547">called </a>&#8220;A Memoir of a Family and Culture in Crisis,&#8221; went on to be a New York Times Bestseller.
Vance's book tells the story of his upbringing in rural Kentucky and later in blue collar Ohio.
"From a former marine and Yale Law School graduate, a powerful account of growing up in a poor Rust Belt town that offers a broader, probing look at the struggles of America's white working class," a description of the book reads.
The movie adaptation of the book starred Glenn Close, Amy Adams and Gabriel Basso, who portrayed Vance. Close was nominated for an Academy Award for Supporting Actress. The film also received an Academy Award nomination for Best Makeup &amp; Hairstyling.
Read Also: <a href="https://www.benzinga.com/news/24/07/39784888/aoc-mocks-trump-vp-choice-j-d-vance-for-tweet-connecting-fertility-rate-with-daylight-saving-time">AOC Mocks Trump VP Choice J.D. Vance For Tweet Connecting Fertility Rate With Daylight Saving Time</a>
Rise at Young Age: The memoir helped Vance gain popularity and later led to a political shift. Vance won a Senate seat in the 2022 election, defeating Democrat Tim Ryan. A Senator since 2023, Vance's selection as the running mate for Trump came with some questions about his age and experience.
Vance will turn 40 in August. If Trump and Vance win the election, the senator will become the youngest vice president since Richard Nixon, who served two terms under President Dwight Eisenhower beginning in 1953.
The Senator would become the third-youngest vice president in American history if Trump wins. Nixon (40) and John Breckenridge (36) would be the only vice presidents younger than Vance.
Born in 1984, Vance is officially the first Millennial to be nominated as a vice-presidential candidate for a major party in a presidential race.  
Venture Capitalist: Before his career in politics, Vance was a venture capitalist and has investment experience in the technology sector and connections to several notable venture capitalists.
Vance was<a href="https://www.benzinga.com/news/24/07/39787707/peter-thiels-ties-with-jd-vance-may-influence-palantir-co-founders-position-on-trump-post-vp-selecti"> a former principal</a> at Peter Thiel's Mithril Capital in 2016 and 2017. He later left Mithril to work at Revolution LLC in 2017, an investment firm founded by AOL founder Steve Case.
In 2019, Vance co-founded Narya Capital, a venture capital fund. The fund received <a href="https://techcrunch.com/2024/07/15/trumps-vp-candidate-j-d-vance-has-long-ties-to-silicon-valley-and-was-a-vc-himself/">backing </a>from Theil, Eric Schmidt and Marc Andreessen.
One of <a href="https://www.benzinga.com/news/24/07/39782144/rumble-stock-rallied-on-monday-heres-what-happened">Narya Capital's investments</a> is in Rumble Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUM#NASDAQ">RUM</a>), a video sharing platform.
Vance was also an <a href="https://x.com/danprimack/status/1812938120381538544">investor </a>in AppHarvest, an indoor faming startup that went public in 2021 via SPAC merger. Vance previously served on the company's board of directors before stepping down in 2021 months after the merger was completed. AppHarvest filed for Chapter 11 bankruptcy in 2023.
Quiver Quant <a href="https://x.com/QuiverQuant/status/1812937994728358057">lists </a>other investments for Vance and his companies as Anduril Technologies, Kriya Therapies and Atmos Nuclear and Space.
Data from Quiver Quant shows that Vance also has investments in several ETFs. Vance's top holdings are the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and SPDR Dow Jones Industrial Average ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>).
Bitcoin Holder: Along with his investments in private companies and through his past venture capital days, Vance is also an investor in cryptocurrency. A <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39785340/trumps-vice-presidential-pick-j-d-vance-holds-bitcoin-supports-pro-crypto-legislation">previous financial disclosure</a> showed Vance owned $100,0000 to $250,000 in Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>).
Along with being a Bitcoin holder, Vance has also been a vocal proponent of the cryptocurrency sector. Vance has been critical of SEC Chairman Gary Gensler's handling of the cryptocurrency sector. The senator is also working on a bill that would work on regulating the cryptocurrency sector.
A February 2022 <a href="https://x.com/JDVance1/status/1493575391457517568">tweet </a>from Vance criticized the ability to freeze bank accounts in Canada.
"This is why crypto is taking off. The regime will cut off your access to banking if you have the wrong politics," Vance tweeted.
The selection of Vance comes as Trump has <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38952866/trump-accepts-cryptocurrency-donations-in-bitcoin-ethereum-shiba-inu-dogecoin-and-more-say">changed his tune</a> about cryptocurrency and has the sector rallying behind him. Analyst Todd Gordon said Bitcoin<a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39786797/bitcoin-could-hit-100k-this-year-with-trump-jd-vances-pro-crypto-presidential-ticket-says-"> could pass $100,000</a> with the pro-crypto ticket of Trump and Vance winning the 2024 election.
Past Criticism of Trump: Before becoming a firm supporter of Trump and his vice-presidential pick, Vance was a critic of the former president. Vance once called Trump a "cynical a&#x2A;&#x2A;hole" and compared him to Adolf Hitler in a private conversation. In public, Vance called Trump "reprehensible" and worried about his political ideology.
"Trump makes people I care about afraid. Immigrants, Muslims, etc. Because of this I find him reprehensible. God wants better of us," Vance said in a since-deleted tweet, as <a href="https://www.washingtonpost.com/elections/2024/07/15/jd-vance-trump-criticism/">reported </a>by The Washington Post.
Vance said he was a "Never Trump guy."
The senator has brushed off the past criticism of Trump in recent <a href="https://www.foxnews.com/media/jd-vance-addresses-past-criticism-trump-after-hes-chosen-vp-bought-medias-lies-distortions">interviews</a>.
"I was certainly skeptical of Donald Trump in 2016, but President Trump was a great president, and he changed my mind," Vance said.
Vance said he "bought into the media's lies and distortions."
"I bought into this idea that somehow he was going to be so different, a terrible threat to democracy. It was a joke."
Vance credited Trump's endorsement in the 2022 election as helping to get him elected to the Senate.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/05/38780518/potential-trump-vp-contender-jd-vance-ready-to-accept-2024-election-results-as-long-as-they-are-free">Potential Trump VP Contender JD Vance Ready To Accept 2024 Election Results As Long As They Are &#8216;Free And Fair&#8217;</a></li>
</ul>
Photo: Consolidated News Photos/Shutterstock.com

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Education

$BTC

SPDR Dow Jones Industrial Average ETF Trust

NFLX

5 Things You Might Not Know About J.D. Vance: 'Hillbilly Elegy' Author, Bitcoin Holder, First Millennial VP Pick And More

Morgan Stanley analyst John Glass maintains Texas Roadhouse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXRH#NASDAQ">TXRH</a>) with a Equal-Weight and raises the price target from $155 to $162.

TXRH

Morgan Stanley Maintains Equal-Weight on Texas Roadhouse, Raises Price Target to $162

Goldman Sachs analyst Richard Ramsden reiterated a Buy rating on Bank Of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) with a price target of $45.
Bank of America reports fiscal 2024 <a target="_blank" href="https://www.benzinga.com/news/earnings/24/07/39790011/bank-of-americas-q2-earnings-revenue-and-eps-beat-1-5b-credit-loss-provision-sees-q4-nii-growth" rel="noreferrer noopener">second-quarter net income</a> of $6.9 billion, beating estimates. Revenue increases 0.8% year over year to $25.5 billion, surpassing expectations.
Bank of America anticipates net interest income of ~$14.50 billion in the fourth quarter.
Ramsden noted the results as slightly better than expectations, given a core Pre-provision Net Revenue&nbsp;(PPNR) of $9.2 billion beat the Street and Goldman Sachs estimate by 2% and 5% on better fees, slightly lower Net Interest Income&nbsp;(NII), and better operating efficiency, with the core Return on Average Tangible Common Shareholders&#8217; Equity&nbsp;(ROTCE) of 13.5%, 25bps above/65bps above the Street and Goldman Sachs estimate.
Ramsden expects the focus to be on the NII outlook from here, after the company guided to $14.5 billion of fiscal fourth-quarter NII (vs. the Street at $14.4 billion), driven by fixed asset repricing, and the Bloomberg Short Term Bank Yield Index&nbsp;(BSBY)&nbsp; reference rate cessation benefit, although the analyst noted that this guidance bakes in 3 Fed Funds rate cuts from September-December.
Ramsden sought further clarity on the 2025 NII outlook, the efficiency outlook for 2024, the trajectory of capital markets revenue in 2024, updates to capital returns, and the pace and magnitude of credit normalization.
Ramsden expects the market to look past the weaker NII this quarter and consider the better fiscal fourth-quarter exit run rate.
The analyst projected fiscal 2024 revenue and EPS of $101.91 billion and $3.13.
Price Action: BAC shares are trading higher by 5.16% at $44.05 at the last check Tuesday.
Photo via Shutterstock

Equities

Reiteration

Bank of America's Growth Boosted by Strong Fees and Operating Efficiency: Goldman Sachs Analyst

Cantor Fitzgerald analyst C J Muse maintains NXP Semiconductors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) with a Overweight and raises the price target from $325 to $350.

NXPI

Cantor Fitzgerald Maintains Overweight on NXP Semiconductors, Raises Price Target to $350

Morgan Stanley analyst John Glass maintains Wingstop (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WING#NASDAQ">WING</a>) with a Equal-Weight and raises the price target from $390 to $400.

WING

Morgan Stanley Maintains Equal-Weight on Wingstop, Raises Price Target to $400

<a href="https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/12037603" title="https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/12037603">https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/12037603</a>